Indications and uses
prevents and treats nausea, vomiting or dizziness due to motion sickness.
prevents and treats nausea, vomiting or dizziness due to motion sickness.
Dosage should be taken one hour before travel starts Adults and children 12 years and older: Chew 1-2 tablets once daily, or as directed by a doctor Children under 12 years: do not give this product to children under 12 years of age unless directed by a doctor
Phenylketonurics: Contains Phenylalanine 0.0025 mg per tablet Store at room temperature in a dry place Keep lid tightly closed
Meclizine HCl, USP 25 mg
Antiemetic
prevents and treats nausea, vomiting or dizziness due to motion sickness.
Do not use in children under 12 years of age unless directed by a doctor
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact the Poison Control Center immediately
aspartame, colloidal silicon dioxide, croscarmellose sodium, dextrose, lake of FD & C Red 40, magnesium stearate, maltodextrin, microcrystalline cellulose, raspberry flavor, sodium sulfate anhydrous, sucrose, tribasic calcium phosphate
Call 1-844-474-7464 Monday to Friday 8 AM - 5 PM ET
Meclizine Hydrochloride Chewable Tablets
25 mg
100 Tablets / 1000 tablets
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 95250459-30e4-45c1-b08a-993044f49109 | Product name | 2 | 20250805 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| 9badc7be-250a-44ab-aa36-926af3f02679 | Product name | 1 | 20210527 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 26acd337-b838-40ac-bcbc-05c3b81c8712 | Product name | 1 | 20170323 |
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68001-529-00 | Meclizine HCl | 100 in 1 BOTTLE | TABLET, CHEWABLE | 100 | 2 | |
| 68001-529-08 | Meclizine HCl | 1000 in 1 BOTTLE | TABLET, CHEWABLE | 1000 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68001-529-00 | EA - Each | 68001-529 | 0e17c453-0e76-44a8-be97-86850ebbce92 | 1 | 2022-04-06 |
| 68001-529-08 | EA - Each | 68001-529 | 392cc8fc-6d12-4f6d-9668-d9477ef4a449 | 1 | 2022-04-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68001-529 | 68001-529-00, 68001-529-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ASPARTAME | Z0H242BBR1 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SODIUM SULFATE ANHYDROUS | 36KCS0R750 | IACT |
| SUCROSE | C151H8M554 | IACT |
| TRIBASIC CALCIUM PHOSPHATE | 91D9GV0Z28 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| RASPBERRY | 4N14V5R27W | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meclizine HCl | MECLIZINE HYDROCHLORIDE CHEWABLE | BluePoint Laboratories | d9cc2705-9dcc-0a73-e053-2995a90aafe6 | 2024-02-21 | Warnings | 68001-529-08 68001-529-00 68001-529 68001052900 68001052908 11d28658-55a1-ff25-e063-6394a90a7e65 d9cc2705-9dcc-0a73-e053-2995a90aafe6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.